O-1602 is primarily studied for its potential therapeutic applications in the field of medical research, particularly in relation to the endocannabinoid system. It is known to interact with GPR55 receptors, which are implicated in various physiological processes, including pain modulation, inflammation, and bone health. Researchers are exploring its potential use in managing chronic pain conditions, as it may offer analgesic effects without the psychoactive properties associated with traditional cannabinoids. Additionally, O-1602 is being investigated for its role in cancer research, where it may influence cell proliferation and apoptosis in certain types of tumors. Its anti-inflammatory properties also make it a candidate for studying inflammatory diseases such as arthritis. Further research is ongoing to fully understand its mechanisms and potential clinical applications.